The susceptibilities of varicella-zoster virus (VZV) and herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) to 17 nucleoside analogs were compared by a plaque reduction assay with human embryonic lung fibroblast cells. The susceptibility of VZV to certain nucleoside analogs was different from that of HSV-1. Against VZV the 5-halogenovinyl-arabinosyluracils were the most potent of the compounds tested.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC180428 | PMC |
| http://dx.doi.org/10.1128/AAC.29.3.524 | DOI Listing |
Publication Analysis
Top Keywords
nucleoside analogs
12
susceptibilities varicella-zoster
8
varicella-zoster virus
8
herpes simplex
8
comparison susceptibilities
4
virus herpes
4
simplex viruses
4
viruses nucleoside
4
analogs susceptibilities
4
virus vzv
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!